# Muhammad Shaheer Bin Faheem

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/muhammad-shaheer-bin-faheem/

## Facts

| Field | Value |
| --- | --- |
| Citations | 88 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 4 |
| i10-index | 0 |
| Last Known Institution | Karachi Institute of Heart Diseases |
| OpenAlex ID | https://openalex.org/A5103038278 |
| ORCID iD | 0009-0005-6878-2031 |
| Works | 140 |

## Researcher papers

- [Clinicopathological spectrum of Diffuse Large B Cell lymphoma: a study targeting population yet unexplored in Pakistan](https://scholariq.org/papers/clinicopathological-spectrum-of-diffuse-large-b-cell-lymphoma-a-study-targeting/)
- [From prediction to precision: Artificial intelligence and emerging technologies in cardiopulmonary resuscitation](https://scholariq.org/papers/from-prediction-to-precision-artificial-intelligence-and-emerging-technologies/)
- [Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death, and geographical disparities in the United States from 1999 to 2020](https://scholariq.org/papers/mortality-trends-of-renal-diseases-due-to-hypertension-in-adults-an-analysis-of/)
- [Toxic heavy metal exposure and heart health: a systematic review and meta-analysis of 324,331 patients](https://scholariq.org/papers/toxic-heavy-metal-exposure-and-heart-health-a-systematic-review-and-meta/)
- [Acoramidis: A Promising Drug for Transthyretin Amyloid Cardiomyopathy](https://scholariq.org/papers/acoramidis-a-promising-drug-for-transthyretin-amyloid-cardiomyopathy/)
- [Between sleep and wakefulness: how sleep quality and stress affect isolated sleep paralysis – a cross-sectional survey](https://scholariq.org/papers/between-sleep-and-wakefulness-how-sleep-quality-and-stress-affect-isolated-sleep/)
- [Trends in Diabetes Mellitus and Associated Mental Disorders‐Related Mortality (1999–2023): A CDC WONDER Database Analysis](https://scholariq.org/papers/trends-in-diabetes-mellitus-and-associated-mental-disorders-related-mortality/)
- [Trends in ischemic heart disease and thromboembolism-related mortality in the United States, 1999–2024: A population-based analysis using CDC WONDER Data](https://scholariq.org/papers/trends-in-ischemic-heart-disease-and-thromboembolism-related-mortality-in-the/)
- [EFFECT OF PERINEURAL ADMINISTRATION OF DEXMEDETOMIDINE WITH BUPIVACAINE VERSUS BUPIVACAINE ALONE IN ULTRASOUND GUIDED SUPRACLAVICULAR BLOCK FOR UPPER EXTREMITY ORTHOPAEDIC OPERATIONS](https://scholariq.org/papers/effect-of-perineural-administration-of-dexmedetomidine-with-bupivacaine-versus/)
- [Role of nicorandil in preventing contrast-induced nephropathy in patients undergoing cardiac catheterization procedures: an updated systematic review and meta-analysis](https://scholariq.org/papers/role-of-nicorandil-in-preventing-contrast-induced-nephropathy-in-patients/)
- [Trends in hypertensive renal disease with renal failure-related mortality among gender ethnicity and states in the United States from 1999–2020](https://scholariq.org/papers/trends-in-hypertensive-renal-disease-with-renal-failure-related-mortality-among/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cardiovascular Health and Risk Factors](https://scholariq.org/topics/cardiovascular-health-and-risk-factors/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [Karachi Institute of Heart Diseases](https://scholariq.org/institutions/karachi-institute-of-heart-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.